1. Academic Validation
  2. Discovery and optimisation of a covalent ligand for TRIM25 and its application to targeted protein ubiquitination

Discovery and optimisation of a covalent ligand for TRIM25 and its application to targeted protein ubiquitination

  • Chem Sci. 2025 May 12;16(23):10432-10443. doi: 10.1039/d5sc01540e.
Katherine A McPhie 1 Diego Esposito 1 Jonathan Pettinger 2 Daniel Norman 3 Thilo Werner 4 Toby Mathieson 4 Jacob T Bush 2 Katrin Rittinger 1
Affiliations

Affiliations

  • 1 Molecular Structure of Cell Signalling Laboratory, The Francis Crick Institute 1 Midland Road London NW1 1AT UK katrin.rittinger@crick.ac.uk.
  • 2 Crick-GSK Biomedical LinkLabs, GSK Gunnels Wood Road, Stevenage Hertfordshire SG1 2NY UK.
  • 3 Chemical Biology, GSK Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK.
  • 4 Cellzome GmbH, a GSK Company Meyerhofstrasse 1 Heidelberg 69117 Germany.
Abstract

The tripartite motif (TRIM) family of RING-type E3 Ligases catalyses the formation of many different types of ubiquitin chains, and as such, plays important roles in diverse cellular functions, ranging from immune regulation to Cancer signalling pathways. Few ligands have been discovered for TRIM E3 Ligases, and these E3s are under-represented in the rapidly expanding field of induced proximity. Here we present the identification of a novel covalent ligand for the PRYSPRY substrate binding domain of TRIM25. We employ covalent fragment screening coupled with high-throughput chemistry direct-to-biology optimisation to efficiently elaborate covalent fragment hits. We demonstrate that our optimised ligand enhances the in vitro auto-ubiquitination activity of TRIM25 and engages TRIM25 in live cells. We also present the X-ray crystal structure of TRIM25 PRYSPRY in complex with this covalent ligand. Finally, we incorporate our optimised ligand into heterobifunctional proximity-inducing compounds and demonstrate the in vitro targeted ubiquitination of a neosubstrate by TRIM25.

Figures
Products